Literature DB >> 23714465

Cellular composition of the tumor microenvironment.

Stephen M Ansell1, Robert H Vonderheide.   

Abstract

In addition to malignant cells, the tumor microenvironment also includes nonmalignant cells, secreted proteins, and blood vessels that surround and support the growth of the tumor. Interactions between the various components of the tumor microenvironment are significant; tumor cells can change the nature of the microenvironment, and conversely, the microenvironment can affect how a tumor grows and spreads. The structure and composition of the tumor microenvironment varies among different types of cancers and between patients. This paper focuses on the composition and function of the tumor microenvironment in hematologic malignancies with a specific focus on B-cell lymphomas.

Entities:  

Mesh:

Year:  2013        PMID: 23714465     DOI: 10.1200/EdBook_AM.2013.33.e91

Source DB:  PubMed          Journal:  Am Soc Clin Oncol Educ Book        ISSN: 1548-8748


  22 in total

1.  Kv1.3 Channels Mark Functionally Competent CD8+ Tumor-Infiltrating Lymphocytes in Head and Neck Cancer.

Authors:  Ameet A Chimote; Peter Hajdu; Alexandros M Sfyris; Brittany N Gleich; Trisha Wise-Draper; Keith A Casper; Laura Conforti
Journal:  Cancer Res       Date:  2016-11-04       Impact factor: 12.701

2.  Oncogenic signaling pathway mediated by Notch pathway-related genes induces immunosuppression and immunotherapy resistance in hepatocellular carcinoma.

Authors:  Peng Ma; Chuanxin Zou; Shitao Xia
Journal:  Immunogenetics       Date:  2022-07-27       Impact factor: 3.330

Review 3.  Breast cancer: molecular mechanisms of underlying resistance and therapeutic approaches.

Authors:  Muhammad Tufail; Jia Cui; Changxin Wu
Journal:  Am J Cancer Res       Date:  2022-07-15       Impact factor: 5.942

4.  Single-Cell RNA-Seq and Bulk RNA-Seq Reveal Intratumoral Heterogeneity and Tumor Microenvironment Characteristics in Diffuse Large B-Cell Lymphoma.

Authors:  Yang Zhao; Hui Xu; Mingzhi Zhang; Ling Li
Journal:  Front Genet       Date:  2022-05-04       Impact factor: 4.772

5.  Effect of timing of bisphosphonate administration on canine osteosarcoma cells undergoing radiation therapy.

Authors:  Katie Hoddinott; Michelle L Oblak; Geoffrey A Wood; Sarah Boston; Anthony J Mutsaers
Journal:  Can J Vet Res       Date:  2020-07       Impact factor: 1.310

Review 6.  A time for YAP1: Tumorigenesis, immunosuppression and targeted therapy.

Authors:  Masahiro Shibata; Kendall Ham; Mohammad Obaidul Hoque
Journal:  Int J Cancer       Date:  2018-07-24       Impact factor: 7.396

7.  Exosomes derived from cancer stem cells of gemcitabine-resistant pancreatic cancer cells enhance drug resistance by delivering miR-210.

Authors:  Zhiyong Yang; Ning Zhao; Jing Cui; Heshui Wu; Jiongxin Xiong; Tao Peng
Journal:  Cell Oncol (Dordr)       Date:  2019-11-12       Impact factor: 6.730

Review 8.  Tumor reversion: a dream or a reality.

Authors:  Avantika Tripathi; Anjali Kashyap; Greesham Tripathi; Joni Yadav; Rakhi Bibban; Nikita Aggarwal; Kulbhushan Thakur; Arun Chhokar; Mohit Jadli; Ashok Kumar Sah; Yeshvandra Verma; Hatem Zayed; Amjad Husain; Alok Chandra Bharti; Manoj Kumar Kashyap
Journal:  Biomark Res       Date:  2021-05-06

9.  Down-regulation of immune checkpoints by doxorubicin and carboplatin-containing neoadjuvant regimens in a murine breast cancer model.

Authors:  Sanambar Sadighi; Ramezanali Sharifian; Monireh Kazemimanesh; Ahad Muhammadnejad; Zahra Shahosseini; Saeid Amanpour; Samad Muhammadnejad
Journal:  Iran J Basic Med Sci       Date:  2021-04       Impact factor: 2.699

Review 10.  Adipose-derived stem cells in ovarian cancer progression, metastasis, and chemoresistance.

Authors:  Wenjing Zhang; Carolina Torres-Rojas; Junming Yue; Bing-Mei Zhu
Journal:  Exp Biol Med (Maywood)       Date:  2021-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.